SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-02-002674
Filing Date
2002-03-25
Accepted
2002-03-25 00:00:00
Documents
11
Period of Report
2001-12-29

Document Format Files

Seq Description Document Type Size
1 NABI BIOPHARMACEUTICALS g74599e10-k.txt 10-K 254476
3 STONEBRIGE ASSOCIATES AGREEMENTS g74599ex10-41.txt EX-10.41 23187
4 EMPLOYMENT AGREEMENT/ THOMAS H. MCLAIN g74599ex10-42.txt EX-10.42 15605
5 EMPLOYMENT AGREEMENT/ MARK L. SMITH g74599ex10-43.txt EX-10.43 15610
6 EMPLOYMENT AGREEMENT/ ROBERT B. NASO g74599ex10-44.txt EX-10.44 16867
7 EMPLOYMENT AGREEMENT/ C. THOMAS JOHNS g74599ex10-45.txt EX-10.45 16384
8 EMPLOYMENT AGREEMENT/ GARY SISKOWSKI g74599ex10-46.txt EX-10.46 16381
9 AMENDMENT NO. 6 TO LOAN & SECURITY AGREEMENT g74599ex10-47.txt EX-10.47 15629
10 STONEBRIDGE ASSOCIATES AGREEMENT g74599ex10-48.txt EX-10.48 20925
11 SUBSIDIARIES g74599ex21.txt EX-21 752
12 CONSENT OF ERNST & YOUNG LLP g74599ex23-1.txt EX-23.1 1052
  Complete submission text file 0000950144-02-002674.txt   399978
Mailing Address P.O. BOX 310701 P O BOX 692222 BOCA RATON FL 33431
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 02584393
SIC: 2836 Biological Products, (No Diagnostic Substances)